MA37836A1 - 5-HT3 Receptor Antagonists - Google Patents
5-HT3 Receptor AntagonistsInfo
- Publication number
- MA37836A1 MA37836A1 MA37836A MA37836A MA37836A1 MA 37836 A1 MA37836 A1 MA 37836A1 MA 37836 A MA37836 A MA 37836A MA 37836 A MA37836 A MA 37836A MA 37836 A1 MA37836 A1 MA 37836A1
- Authority
- MA
- Morocco
- Prior art keywords
- receptor antagonists
- disorders
- compounds
- present
- receptor
- Prior art date
Links
- 102000035037 5-HT3 receptors Human genes 0.000 title abstract 3
- 108091005477 5-HT3 receptors Proteins 0.000 title abstract 3
- 239000002464 receptor antagonist Substances 0.000 title abstract 2
- 229940044551 receptor antagonist Drugs 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 206010047700 Vomiting Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 206010013663 drug dependence Diseases 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- 230000000626 neurodegenerative effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 208000020016 psychiatric disease Diseases 0.000 abstract 1
- 208000011117 substance-related disease Diseases 0.000 abstract 1
- 230000008673 vomiting Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention concerne des antagonistes du récepteur 5-ht3 de formule (i) qui sont utiles pour le traitement de maladies pouvant être traitées par l'inhibition du récepteur 5-ht3, tels que le vomissement, la douleur, la pharmacodépendance, les troubles neurodégénératifs et psychiatriques, et les troubles gastro-intestinaux. La présente invention concerne en outre des compositions pharmaceutiques contenant de tels composés et des procédés pour préparer de tels composés.The present invention relates to 5-HT 3 receptor antagonists of formula (i) which are useful for the treatment of diseases that can be treated by inhibition of the 5-HT 3 receptor, such as vomiting, pain, drug dependence, disorders. neurodegenerative and psychiatric disorders, and gastrointestinal disorders. The present invention further relates to pharmaceutical compositions containing such compounds and methods for preparing such compounds.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261672709P | 2012-07-17 | 2012-07-17 | |
| PCT/US2013/050746 WO2014014951A1 (en) | 2012-07-17 | 2013-07-16 | 5-ht3 receptor antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA37836A1 true MA37836A1 (en) | 2018-03-30 |
| MA37836B1 MA37836B1 (en) | 2018-10-31 |
Family
ID=58530739
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA37836A MA37836B1 (en) | 2012-07-17 | 2013-07-16 | 5-HT3 Receptor Antagonists |
Country Status (2)
| Country | Link |
|---|---|
| MA (1) | MA37836B1 (en) |
| UA (1) | UA113991C2 (en) |
-
2013
- 2013-07-16 UA UAA201500605A patent/UA113991C2/en unknown
- 2013-07-16 MA MA37836A patent/MA37836B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| UA113991C2 (en) | 2017-04-10 |
| MA37836B1 (en) | 2018-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA43169B1 (en) | Heterocyclic compounds as pi3k-gamma inhibitors | |
| MA37762A1 (en) | N-aryltriazole compounds used as antagonists of lpar | |
| MA37764A1 (en) | N-alkyltriazole compounds used as antagonists of lpar | |
| MA40111B1 (en) | Derivatives of tetrahydronaphthalene inhibiting mcl-1 protein | |
| MA31158B1 (en) | Tricyclic compounds and their use as modifiers for glucocorticoid receptors. | |
| EA201170624A1 (en) | ISONICOTINAMIDE ANTAGONISTS OF OREXIN RECEPTORS | |
| MA37888B1 (en) | Coated pharmaceutical composition containing regorafenib | |
| EA201390683A1 (en) | PIPERIDINONCARBOXAMIDAZAZINDANES - CGRP RECEPTOR ANTAGONISTS | |
| MA30232B1 (en) | HYDANTOIN BASED KINASE INHIBITORS | |
| IN2015DN00957A (en) | ||
| MA45598B1 (en) | 24-hydroxy steroles substituted in position 11 for the treatment of diseases linked to the nmda receptor | |
| MA40955A (en) | 2-AMINO-6- (DIFLUOROMETHYL) -5,5-DIFLUORO-6-PHENYL-3,4,5,6-TETRAHYDROPYRIDINES AS BACE1 INHIBITORS | |
| WO2019007696A1 (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of fibrosis | |
| MA35271B1 (en) | Antagonists of trpm8 and their use in treatments | |
| MA34545B1 (en) | CO-CRYSTALS AND SALTS OF CCR3 INHIBITORS | |
| MA34968B1 (en) | ASYMMETRIC UREA AND MEDICAL USES THEREOF | |
| MA37439A1 (en) | Cyclic ether bridge dgat1 inhibitors for the treatment of acyl mediated disorders coa-diacylglycerol transferase 1 (dgat1). | |
| MA37765A1 (en) | Substituted pyrazole compounds used as lpar antagonists | |
| MA42776B1 (en) | Compounds useful for inhibiting t-ror | |
| MA39253B1 (en) | Substituted bicyclic heteroaryl compounds used as rxr agonists | |
| MA43913B1 (en) | Positive allosteric modulators of the m1 muscarinic receptor | |
| MA38250B1 (en) | New hydantoin derivatives for their uses in the treatment of diseases, such as osteoporosis and thrombocytopenia | |
| MA37836A1 (en) | 5-HT3 Receptor Antagonists | |
| EA201290532A1 (en) | BICYCLIC THIAZOLES AS AN ALLYSTERIC MODULATORS OF MGLUR5 RECEPTORS | |
| MA37879B1 (en) | Stabilized amorphous form of agomelatine, process for its preparation and pharmaceutical compositions containing it |